| 000 -LEADER |
|---|
| fixed length control field |
00963naa a2200181uu 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
10039 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
OSt |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20190211154913.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
030115s2005 xx ||||gr |0|| 0 eng d |
| 999 ## - SYSTEM CONTROL NUMBERS (KOHA) |
|---|
| Koha Dewey Subclass [OBSOLETE] |
PHL2MARC21 1.1 |
| 041 ## - LANGUAGE CODE |
|---|
| Language code of text/sound track or separate title |
eng |
| 100 1# - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
CHAMPION, David |
| 9 (RLIN) |
2098 |
| 245 10 - TITLE STATEMENT |
|---|
| Title |
Mastering the value chain : |
| Remainder of title |
an interview with Mark Levin of Millennium Pharmaceuticals |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. |
|---|
| Date of publication, distribution, etc. |
2001 |
| 520 3# - SUMMARY, ETC. |
|---|
| Summary, etc. |
An industry in flux creates vast opportunities. But to seize them, a company must understand how the current upheavals will affect the future distribution of profits and then reinvent itself to capitalize on the new sources of value. In this interview, CEO Mark Levin describes how Millennium Pharmaceuticals balances long-term strategy with short-term tactics to expand its reach across the pharmaceutical value chain |
| 773 08 - HOST ITEM ENTRY |
|---|
| Title |
Harvard Business Review |
| Related parts |
79, 6, p. 108-115 |
| Place, publisher, and date of publication |
, 2001 |
| Record control number |
|
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Koha item type |
Periódico |
| 998 ## - LOCAL CONTROL INFORMATION (RLIN) |
|---|
| -- |
20030115 |
| Operator's initials, OID (RLIN) |
Cassio |
| Cataloger's initials, CIN (RLIN) |
Cassio |
| 998 ## - LOCAL CONTROL INFORMATION (RLIN) |
|---|
| -- |
20060605 |
| Operator's initials, OID (RLIN) |
1339^b |
| Cataloger's initials, CIN (RLIN) |
Quiteria |
